On this week’s episode of “The Readout LOUD”: a drug-industry profession reshaped by sickness, and the potential for political blowback towards Chinese language biotech.
Listeners of this podcast most likely know pharma marketing consultant Mike Rea for his annual rating of drug firm R&D productiveness. However this week, he penned a poignant private essay explaining how some medical setbacks have impacted his skilled life. He joins us to debate.
However first, President Trump is contemplating a major crackdown on medicine invented in China, based on a current report within the New York Instances. Trade assist for the attainable measures are blended, nevertheless. Whereas strengthening the U.S. biopharma {industry} garners broad assist, so too does the liberty to supply progressive medicine from Chinese language biotechs.
Be certain to join “The Readout LOUD” on Apple Podcasts, Spotify, or wherever you get your podcasts.
